NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

Consider virtually all of the "believers" are taking money from NWBO, The true test is whether regulators will accept the data and then approve it for commercial use. Until then, it is just a lot of noise without any benefit -- share price is no better, down ~50% in a year even after the TLD. TLD created no increase in shareholder value. That tells you that the investment community is certainly not buying it, regardless of how long your list is.